Skip to main content

Table 3 Blood pressure and rates of hypertension in adulthood by MTHFR genotype

From: Impact of the common MTHFR 677C→T polymorphism on blood pressure in adulthood and role of riboflavin in modifying the genetic risk of hypertension: evidence from the JINGO project

 

MTHFR genotype

 

CC

CT

TT

P valueb

Total cohort (up to 90 years)

n = 2635

n = 2606

n = 719

 

 Age, years

68.9 (68.3, 69.5)

69.0 (68.4, 69.6)

68.6 (67.5, 69.7)

0.806

 Systolic BP, mmHg

140.7 (139.8, 141.5)

141.5 (140.8, 142.4)

141.1 (139.6, 142.6)

0.373

 Diastolic BP, mmHg

78.0 (77.6, 78.4)

78.5 (78.0, 78.9)

78.4 (77.6, 79.2)

0.258

 Hypertension, n (%)

1373 (51%)

1411 (53%)

373 (50%)

0.302

Adults 18 to 70 years

n = 1124

n = 1138

n = 313

 

 Age, years

56.3 (55.4, 57.1)

56.4 (55.6, 57.3)

55.8 (54.2, 57.5)

0.835

 Systolic BP, mmHg

135.0 (133.9, 136.0)a

136.1 (135.0, 137.2)ab

137.6 (135.5, 139.6)b

0.026

 Diastolic BP, mmHg

79.4 (78.9, 80.0)a

80.0 (79.4, 80.5)ab

81.4 (80.3, 82.5)b

0.013

 Hypertension, n (%)

464 (40)

514 (44)

149 (46)

0.072

  1. CC (wild type), CT (heterozygous), TT (homozygous variant), genotypes for the MTHFR 677C→T polymorphism
  2. Data are expressed as mean (95% CI) for age, as adjusted mean (95% CI) for blood pressure, and n (%) for hypertension
  3. BP blood pressure
  4. aHypertension defined as systolic BP of ≥ 140 and/or a diastolic BP of ≥ 90 mmHg [1]
  5. bDifferences in blood pressure between genotype groups were assessed by one-way ANCOVA with adjustment for age, sex, BMI, alcohol, total cholesterol, antihypertensive drugs use and study cohort following log-transformation of data for normalisation purposes, as appropriate. Different superscript letters (i.e. a, b) within a row indicate significant differences by Bonferroni post hoc test, whilst the same letter (i.e. a, a) indicates no significant differences. Categorical variables were assessed using chi-square analysis